Advanced Drug Delivery Reviews Journal Citation Rate 2026

ISSN 0169-409X eISSN 1872-8294 Elsevier BV NL

Q1 Quartile Top Tier

About Advanced Drug Delivery Reviews
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Advanced Drug Delivery Reviews (ADDR) is a peer-reviewed academic journal covering Advanced Drug Delivery Systems and Diverse Scientific and Economic Studies, published by Elsevier BV in NL, catalogued under ISSN 0169-409X (e-ISSN 1872-8294). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 12.22 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$5150 USD).

Advanced Drug Delivery Reviews Citation Rate 2026 — In Context

Advanced Drug Delivery Reviews has a 2025 2-Year Citation Rate (OpenAlex) of 12.22, placing it in the Q1 quartile within the Advanced Drug Delivery Systems research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Advanced Drug Delivery Reviews operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Advanced Drug Delivery Reviews should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Advanced Drug Delivery Reviews against similar journals in the field, use our journal comparison tool.

Submission Tips for Advanced Drug Delivery Reviews
  • Budget $5150 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Advanced Drug Delivery Systems, Diverse Scientific and Economic Studies, Human auditory perception and evaluation. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Advanced Drug Delivery … Compares
Citation Rate vs Field Avg
+263%
Field avg: 3.37
APC vs Field Avg
+51%
Field avg: $3417

Compared against 90 journals in the same research areas.

ISSN (Print) 0169-409X
ISSN (Online) 1872-8294
Publisher Elsevier BV
Country Netherlands
APC / Cost $5150 USD
In-depth profile & metrics

Advanced Drug Delivery Reviews is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 5150.

In our subject taxonomy, Advanced Drug Delivery Reviews is classified under Advanced Drug Delivery Systems, Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Nanoparticle-Based Drug Delivery.

Advanced Drug Delivery Reviews is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 12.217.

Research Areas
Links
Frequently Asked Questions about Advanced Drug Delivery Reviews

Advanced Drug Delivery Reviews does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 12.217 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Advanced Drug Delivery Reviews is not an open access journal.

The Article Processing Charge (APC) for Advanced Drug Delivery Reviews is $5150 USD.

Advanced Drug Delivery Reviews is published by Elsevier BV.

Advanced Drug Delivery Reviews shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Advanced Drug Delivery Reviews is 0169-409X. Its electronic ISSN (eISSN) is 1872-8294.

Advanced Drug Delivery Reviews sits in the Q1 quartile based on its latest impact factor of 12.22, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
12.217
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 12.217 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S114437232

Get weekly updates for Advanced Drug Delivery Systems journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google